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Sir,
I would like to thank Drs Hung and Shih for
commenting on our article.1 As they mentioned
in their letter, surgical resection has been the stan-
dard local therapy for hepatocellular carcinoma
until other less invasive modalities of treatment
emerged, such as percutaneous ethanol injection
(PEI) and radiofrequency thermal ablation (RFA),
especially for smaller tumors. That is why we
wanted to investigate whether there is any role
for surgical treatment of this high-risk disease in
terms of multiple lesions in the liver. If the results
of surgical and nonsurgical therapy are not dif-
ferent, then patients need not undergo the more
invasive surgical treatment.
First, in their letter, the authors mentioned that
“both the treated and non-treated patients did
not add up to the number of recurrence of 93”.
This is because as the indications for the modali-
ties of treatment might be different in the follow-
up discovery of recurrences, each patient might
receive more than one kind of treatment during
their postoperative lifetime.
Second, with regard to our control group, we
selected those with serum albumin level ≥3.5 g/dL,
total bilirubin level < 2 mg/dL, tumor number 
≤ 3 and tumor size ≤ 5 cm from our database of
874 patients (actually 178 patients with tissue
proof as stated in our article) who underwent
nonsurgical treatment. Certainly, there might be
selection bias and we admitted it. However, this
is the only way to make both the surgical and
nonsurgical groups match, and the comparison
is important for we had to know if there was any
benefit for surgery. In addition, only those with
small tumors could undergo PEI or RFA, which
was advocated by the authors.
Third, and the most important statements the
authors made, “…the overall cumulative survival…
leveled off at 5 years (26.2% vs. 22.6%). Surgical
resection is not any better than nonsurgical treat-
ment in the long term.” In fact, we had already
clearly shown in the first part of the study that one-
block resection was the only independent factor
to be associated with better prognosis for those
who underwent hepatectomy. In the second part of
our study comparing the surgical and nonsurgical
groups, we showed in Figures 3 and 4 that the dif-
ference in overall survival was contributed to by
those who received one-block resection. In other
words, patients might benefit from surgical resec-
tion only when one-block resection can be con-
ducted if they have acceptable liver function reserve.
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